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RIG-I and MDA5 sense virus-derived short 50ppp
blunt-ended or long dsRNA, respectively, causing
interferon production. Non-signaling LGP2 appears
to positively and negatively regulate MDA5 and
RIG-I signaling, respectively. Co-crystal structures
of chicken (ch) LGP2 with dsRNA display a fully or
semi-closed conformation depending on the pres-
ence or absence of nucleotide. LGP2 caps blunt,
30 or 50 overhang dsRNA endswith 1 bp longer overall
footprint than RIG-I. Structures of 1:1 and 2:1 com-
plexes of chMDA5 with short dsRNA reveal head-
to-head packing rather than the polar head-to-tail
orientation described for long filaments. chLGP2
and chMDA5 make filaments with a similar axial
repeat, although less co-operatively for chLGP2.
Overall, LGP2 resembles a chimera combining
a MDA5-like helicase domain and RIG-I like CTD
supporting both stem and end binding. Function-
ally, RNA binding is required for LGP2-mediated
enhancement of MDA5 activation. We propose
that LGP2 end-binding may promote nucleation of
MDA5 oligomerization on dsRNA.
INTRODUCTION
Homologousdouble-strandedRNA (dsRNA) dependent ATPases
RIG-I,MDA5, andLGP2 (RIG-I-like helicases [RLHs]) are keycyto-
solic pattern recognition receptors in the vertebrate innate im-
mune response against RNA viruses. RIG-I senses primarily
50ppp blunt-end dsRNA (50ppp-dsRNA), whereas MDA5 is acti-
vated by long dsRNA. Consequently, the two sensors respond
to different but overlapping sets of viruses (Yoo et al., 2014).
Both activated receptors trigger the same downstream signaling586 Molecular Cell 62, 586–602, May 19, 2016 ª 2016 The Author(s).
This is an open access article under the CC BY license (http://creativepathway, leading to interferon (IFN) induction (Goubau et al.,
2013). RIG-I andMDA5possess tandemN-terminal caspase acti-
vation and recruitment domains (CARDs), a central DECH-box
helicase domain (Fairman-Williams et al., 2010), and a C-terminal
domain (CTD). LGP2differs in lackingCARDs (Figure 1A) and thus
independent signaling activity.
Extensive studies of RIG-I and MDA5 have elucidated their
mode of RNA binding and activation and signaling mechanisms
(Ahmad and Hur, 2015; Hopfner, 2014). RIG-I binding to short
50ppp-dsRNA via its CTD and helicase domains releases the
CARDs from an auto-inhibitory state, in an ATP-dependent
manner (Kowalinski et al., 2011). This allows them to interact
with and oligomerize, in a poly-ubiquitin-dependent fashion,
downstream signaling partner MAVS (Peisley et al., 2014; Wu
et al., 2014). By contrast, MDA5 binds co-operatively to long
dsRNA to form protein-coated filaments (Berke et al., 2012; Peis-
ley et al., 2011; Wu et al., 2013); the resulting oligomerization of
MDA5 CARDs activates MAVS (Wu et al., 2013).
LGP2 is reported to be both a positive and negative regulator
of the anti-viral response (Rodriguez et al., 2014; Zhu et al.,
2014). A positive role for LGP2 in anti-viral signaling is supported
by the higher susceptibility of LGP2 knockout mice to certain
RNA viruses (Satoh et al., 2010) and co-operative activity with
MDA5 (Childs et al., 2013). Indeed, small amounts of LGP2
enhance MDA5-mediated signaling (Bruns et al., 2014), and a
picornavirus-derived MDA5 agonist was found through its inter-
action with LGP2 (Deddouche et al., 2014). Furthermore, LGP2,
like MDA5, is specifically targeted for inactivation by paramxyo-
virus V protein (Childs et al., 2012; Rodriguez andHorvath, 2013).
A negative role for LGP2 emerged from inhibitory activity
observed upon overexpression of LGP2 (Bruns et al., 2013;
Liniger et al., 2012, and references therein).
To gain further insight into the role of LGP2 in the anti-viral
response and its co-operative role in MDA5 signaling, we
performed structural, biochemical, and cell-based studies on
chicken (ch) LGP2 and MDA5. Interestingly, chicken (Barber
et al., 2010) and another Galliforme, turkey (according to its
draft genome), both lack a RIG-I gene, unlike other vertebrates,Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Overall Structure of chLGP2-dsRNA-ADP:AlF4 Complex
(A) Domain structure of chLGP2. Domain colors are green (Hel1), yellow (Hel2i), cyan (Hel2), red (pincer motif), and orange (CTD).
(B) Side and head-end cartoon view of chLGP2-dsRNA-ADP:AlF4 complex (left and middle) compared with hRIG-I-dsRNA-ADP:BeF3 complex (PDB: 5E3H
[3TMI]) (right). In the side view, the head end contains the pincer motif and the tail end contains the CTD. Domain colors are as in (A), with the zinc atom in
the CTD a black sphere. The dsRNA 30 and 50 strands are, respectively, violet and yellow. The ADP:AlF4 is in spheres representation. Note that the second pincer
domain helix (a19) of chLGP2 extends right up to the CTD, unlike in hRIG-I.
(legend continued on next page)
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including many birds (Chen et al., 2013). Nevertheless, chicken
cells express MDA5, LGP2, and MAVS (Karpala et al., 2011; Li-
niger et al., 2012) and produce type I IFN in response to highly
pathogenic avian influenza virus, most likely via chMDA5 in
co-operation with chLGP2 (Hayashi et al., 2014; Liniger et al.,
2012). We present the crystal structure of chLGP2 bound to
50 mono-phosphate (50p), 50 tri-phosphate (50ppp), and 30 over-
hang dsRNA at, respectively, 1.5, 2.2, and 2.0 A˚ resolution and
characterize the RNA binding and ATPase activity of chLGP2
and human (h) LGP2. We also report crystal structures of 1:1
and 2:1 CARD-deleted chMDA5-dsRNA complexes at, respec-
tively, 2.60 and 2.75 A˚ resolution. We demonstrate by electron
microscopy (EM) that both chMDA5 and chLGP2 make fila-
ments with dsRNA with the same axial repeat. Finally, func-
tional studies reveal that LGP2 enhanced poly(I:C)-dependent
MDA5 signaling, in both chicken and human cells, requires an
intact RNA binding site on both the LGP2 helicase and CTD
domains.
RESULTS
Overall Structure of chLGP2
We determined three co-crystal structures of full-length chLGP2
with the ATP transition state analog adenosine 50-diphosphate:
aluminum fluoride (ADP:AlF4) and either a 10-mer palindromic
50p dsRNA (chLGP2_10p) or 50ppp dsRNA (chLGP2_10ppp) or
a 50ppp and 30 two nucleotide (GG) overhang hairpin RNA duplex
(chLGP2-3ovg) at, respectively, 1.5, 2.2, and 2.0 A˚ resolution.
A fourth structure of chLGP2 bound to a 12-mer palindromic
dsRNA has no bound nucleotide. See Table 1 for crystallographic
details.
Overall, chLGP2 resembles other dsRNA-bound RLHs with
the two RecA-like helicase domains (Hel1, Hel2), helicase inser-
tion domain (Hel2i), pincer domain (P), andCTDwrapping around
the dsRNA stem. Hel1 contains the conserved helicase motifs Q,
I, Ia, Ib, Ic, II, IIa, and III, whereas Hel2 contains motifs IV, IVa, V,
Va, and VI (Figures 1A and 1B; see also Figure S1 for the second-
ary structure of chLGP2 and sequence alignment with other
RLHs). The unusually high resolution of the structures reveals
details of the ADP:AlF4 binding site and the highly hydrated
chLGP2-dsRNA interface. One distinctive feature of LGP2 is
that the second pincer domain helix (a19) has eight turns and
connects directly to the CTD, whereas in RIG-I, a19 has only
six turns, followed by an extended, proline-rich connecting pep-
tide (Figure 1B). Thus in LGP2, the CTD-pincer linkage appears
to be more constrained and lacking the functionally important
flexibility observed in RNA free RIG-I (Kowalinski et al., 2011).
The structure of chLGP2-dsRNA-ADP:AlF4 complex is in a highly
ordered, closed conformation, mimicking the transition state(C) Details of the immediate protein ligands of the ADP:AlF4:Mg
2+ bound in chLGP2
and VI (Hel2), which are colored as indicated. The Mg2+ ion, aluminum, and fluo
Gln465 coordinate the mimic of the attacking water molecule (red sphere) in this
(D) Diagram showing how in chLGP2, Glu67 emerges from helix a3 to be involved
base (top). A very similar situation occurs in MDA5 (see Figure 4D) but not RIG-I
(E) Left: table of Km and kcat values for the RNA-dependent ATPase activity of w
curves for chLGP2 and hLGP2 with without dsRNA and various mutations of chL
See also Figures S1–S3.
588 Molecular Cell 62, 586–602, May 19, 2016for ATP hydrolysis, and thus most closely resembles the duck
RIG-IDCTD-dsRNA-ADP:AlF4 complex (dRIG-I; Protein Data
Bank [PDB]: 4A36) (Kowalinski et al., 2011) in the disposition
of the domains, except that the CTD is present as well. In the
chLGP2 structure without nucleotide, the helicase is in a semi-
closed state with Hel2 separated from Hel1 and partially disor-
dered. See the Discussion for an analysis of the different
nucleotide-dependent conformations observed for RLHs.
ADP:AlF4 Binding and ATPHydrolysis Activity of chLGP2
ADP:AlF4 is tightly bound at the interface between the chLGP2
Hel1 and Hel2 with conserved motifs Q, I, and II from Hel1 and
motifs Va and VI from Hel2 engaged in the interaction (Figures
1C and S2A). The adenosine base is partially stacked between
His4 (motif Q) and LGP2 conserved Arg32 (motif I), and base-
specific interactions are provided by the main-chain carbonyl
of Glu2 and side chain of Gln7 (motif Q). This differs from
RIG-I, where the base stacks between motif Q Arg244 (hRIG-I)
and motif I Phe272 (equivalent to His4 and Arg32 in LGP2,
respectively). The ADP ribose hydrogen bonds with conserved
Glu67, which itself is stabilized by a salt bridge with Arg32
(Figures 1C and 1D). Glu67 emerges from a kink in helix a3 (Fig-
ure 1D), a feature that is conserved in MDA5 (see below; Fig-
ure S1), but not RIG-I, where the equivalent helix is straight
and not involved in nucleotide binding (Figure 1D). Motif I
(25-PTGAGKTR-32) wraps around the a- and b-phosphates
of the ADP, making several hydrogen bonds. Motif Va (440-
EEGLD-444) and motif VI (467-QGRARA-472) directly interact
with ADP:AlF4, a characteristic of the closed form. Motif Va
Asp444 interacts with the ADP ribose and stabilizes Arg471 of
motif VI. Arg471 interacts with the a-phosphate and two fluorines
of AlF4. Arg469, stabilized by Gln465, interacts with a third
fluorine, mimicking stabilization of the transition state (Figures
1C and S2B). The high-resolution structure reveals the com-
plex hydrogen bonding network involving Asp131 and Glu132
(motif II), AlF4, Mg
2+, and water molecules in the presumed tran-
sition state. The octahedrally coordinated Mg2+ ion ligates one
oxygen atom of the b-phosphate, two fluorine atoms, and three
water molecules. Two magnesium coordinated water molecules
form direct contacts with the side chains of Thr31 (motif I) and
Asp131 (motif II) (Figures 1C and S2B). One water molecule co-
ordinated by Glu132 (motif II, DECH) and Gln465 (motif VI) likely
represents the attacking nucleophilic water, which catalyzes
ATP hydrolysis (Figures 1C and S2B).
According to Bruns et al. (2013), hLGP2 has significant
basal (dsRNA-independent) ATPase activity. We find that both
chLGP2 and hLGP2 ATPase activity is strictly dsRNA dependent
(Figure 1E). UnlikeMDA5, the activity is not dsRNA length depen-
dent (Figures S2C and S2D). Moreover the ATP catalytic, all of which (except Glu67) come from helicasemotifs Q, I and II (Hel1), and Va
rine atoms are, respectively, purple, gray, and light blue spheres. Glu132 and
transition-state analog complex.
in ATP ribose binding and stabilization of Arg32, which stacks on the adenine
(bottom).
ild-type chLGP2, dRIG-I, and chMDA5. Right: representative ATP hydrolysis
GP2. See also Figure S2.
Table 1. Diffraction Data and Refinement Statistics for chLGP2
Crystal chLGP2
50ppp 10-mer
dsRNA
ADP:AlF4:Mg
2+
chLGP2
50p 10-mer
dsRNA
ADP:AlF4:Mg
2+
chLGP2
50ppp 10-mer
30 ovg dsRNA
ADP:AlF4:Mg
2+
chLGP2
50p 12-mer
dsRNA
Diffraction data
Space group P212121 P212121 P212121 P64
Cell dimensions (A˚) a = 70.14, b = 96.58 a = 69.59, b = 97.05 a = 69.86, b = 97.43 a = b = 90.09,
c = 122.86 c = 122.52 c = 122.58 c = 196.73
a = b = g = 90 a = b = g = 90 a = b = g = 90 a = b = 90, g = 120.00
Wavelength (A˚) 0.8726 0.9786 1.072 0.9786
Resolution range of data (last shell) (A˚) 50.0–2.2 (2.28–2.2) 50.0–1.50 (1.55–1.50) 50.0–2.0 (2.10–2.0) 45.04–3.60 (3.73–3.60)
Completeness (last shell) (%) 99.9 (99.4) 99.9 (99.8) 99.9 (98.7) 99.8 (99.0)
R-sym (last shell) (%) 16.9 (83.5) 4.8 (74.6) 25.9 (79.5) 6.7 (118.0)
I/sI (last shell) 8.73 (1.87) 17.6 (2.31) 6.31 (1.38) 20.74 (2.01)
Redundancy (last shell) 6.64 (6.50) 5.25 (5.27) 4.47 (4.35) 11.51 (10.32)
Refinement
Reflections used in refinement work (free) 40,943 (2,114) 126,226 (6,681) 53,847 (2,814) 10,121 (542)
R-work (last shell) 0.188 (0.267) 0.133 (0.244) 0.218 (0.333) 0.253 (0.359)
R-free (last shell) 0.245 (0.294) 0.168 (0.292) 0.255 (0.317) 0.319 (0.346)
Number of non-hydrogen atoms 6,458 6,638 6,188 5,540
Protein 5,616 5,531 5,356 5,028
RNA 464 495 506 512
Ligand (nucleotide) 33 33 33 –
Solvent 345 579 293 –
Geometry and B factors
Rms (bonds) 0.009 0.013 0.008 0.006
Rms (angles) 1.365 1.510 1.278 0.954
Ramachandran favored (%) 97.1 98.4 97.5 94
Ramachandran outliers (%) 0.72 0.15 0.15 0.32
Clash score 1.59 3.70 1.93 1.11
Average B factor 34.0 29.9 39.2 202.8
Protein 34.3 29.5 39.4 205.9
RNA 30.8 22.8 36.7 173.1
Ligand (nucleotide) 20.4 22.9 30.4 –
Solvent 33.6 40.7 38.7 –
Rms, root-mean-square.efficiency, as indicated by kcat/Km, is much lower for both
chLGP2 and chMDA5 than for dRIG-I (Figures 1E and S2C).
The importance of the interaction of Glu67 with the nucleotide
ribose is underlined by the abolished ATPase activity of a
chLGP2 K66A/E67A mutant (Figure 1E). Within the highly
conserved motif I sequence (25-PTGAGKTR-32, chLGP2) the
fourth position differs, being C/S in RIG-I, S in MDA5, and
A/G/S in LGP2 (Figure S2E), and an A28C mutation abolishes
the ATPase activity of chLGP2 (Figure 1E). Glu132 (motif II) (Civril
et al., 2011; Louber et al., 2015) and Gly468 (motif VI; Figure S2F)
(Funabiki et al., 2014) are absolutely conserved and crucial for
ATP hydrolysis by RIG-I and MDA5, correlating with their muta-
tion underlying genetic disease (Funabiki et al., 2014; Jang et al.,
2015). Accordingly, E132Q or G468S mutations abolish the
ATPase activity of chLGP2 (Figure 1E).Recognition of dsRNA by chLGP2
Because of the full closure of all domains around the dsRNA
(Figure 2A), many residues of chLGP2 make direct interactions
to the dsRNA. These are detailed in Figure 2B, in which
numerous water-mediated protein-RNA or direct water-RNA in-
teractions are omitted for clarity. The protein-RNA interface
buries a total solvent accessible surface of 4,700 A˚2 (10p) or
4,786 A˚2 (10ppp), as compared with 3,109 A˚2 for hRIG-I in
the semi-closed state (PDB: 5E3H [3TMI]). RNA binding resi-
dues come from the CTD and the conserved motifs Ia, Ib, Ic,
and IIa from Hel1 and IV, IVa, and V from Hel2. In addition,
Hel2i and the pincer domain interact with the dsRNA. Hel2i res-
idues from helix a10 (Gln256, Gln260, Arg261, Glu264, and
Asn267) as well as Arg285 from helix a11 interact with both
dsRNA strands via the minor groove. Arg486 and Arg490Molecular Cell 62, 586–602, May 19, 2016 589
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Figure 2. dsRNA Binding by chLGP2
(A) Surface representation of the chGP2-dsRNA-ADP:AlF4 complex viewed from the tail (left) and head (right) ends, colored as in Figure 1. At the tail end, the
protein completely caps the blunt end of the dsRNA, whereas at the head end, the dsRNA can be extended.
(legend continued on next page)
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from the long helix a18 of the pincer domain also interact
directly with the phosphate backbone of the dsRNA 50 strand.
The above-cited interacting residues are conserved or conser-
vatively substituted polar residues in LGP2 from different or-
ganisms (Figure S3).
Within the full-length chLGP2 structure, the CTD interacts with
the dsRNA extremity in a similar fashion to previously reported
for the isolated hLGP2 CTD (PDB: 3EQT) (Li et al., 2009; Pippig
et al., 2009), with the terminal base pair (50-G1:C1*-30) making
extensive hydrophobic interactions with aromatic residues
Phe595, Phe599, and Trp602 from the 591–602 ‘‘capping
loop’’ between strands b18 and b19 (Figure 2C). This loop also
makes significant contacts with Hel1 in the vicinity of motif Ib,
thereby reinforcing the closure of LGP2 over the RNA. The 30
end interacts mainly with the turn between strands b16 and
b17 (the 571–574 ‘‘30 end-binding loop’’; Figure S1), with fully
conserved Glu571 hydrogen bonding with both hydroxyls of
C1* and His574 bridging between the C1* and G2 riboses (Fig-
ure 2C). These interactions would appear to block extension of
the 30 strand of the dsRNA (but see below). The 50 end interacts
with both the CTD and the extended 402–413 ‘‘Hel2-loop’’ (Fig-
ure S1), which emerges between strand b10 and helix a16 and
crosses the major groove of the dsRNA (Figure 2C). In chLGP2,
the G1 base is imperfectly stacked between His406 and tilted
Phe595, whereas the equivalent residues in hLGP2 are aliphatic,
Asn408 and Ile597, respectively. Interestingly, an aromatic resi-
due (His or Tyr) is found at position 406 in the Hel2-loop only in
bird, reptile, and amphibian LGP2s (i.e., not in mammals or
fish, in which it is usually an Asn), whereas only birds (with a
few exceptions) and frogs have an aromatic residue at position
595 (Figure S3). The deletion of theHel2-loop significantly affects
ATP hydrolysis by hMDA5 (Wu et al., 2013). We found that the
H406A mutation in chLGP2 also reduced ATP hydrolysis but
did not significantly change the affinity to RNA (Figures 1E and
3B). The CTD of LGP2 contains a lysine-rich motif (644-
KKKYKKWS-651), with highly conserved Lys648 and Lys649
contacting phosphates of both strands across the major groove
(respectively A7*, U8*, and C5) and conserved Trp650 to U3 and
A4 phosphates (Figure 2B). The K648/K649E double mutation
reduces chLGP2 affinity to dsRNA 56 times compared with
wild-type (WT). A quadruplemutant with the additional glutamate
substitutions of the conserved helicase residues Lys138 and
Arg490 that interact with consecutive 50 strand phosphates (Fig-
ure 2B) has 1,500 times less affinity, while the helicase muta-
tions alone reduce the affinity by only 2.7 times (Figure 3B).
This confirms the strong direct binding of the CTD to the RNA(B) Schematic diagram showing the interactions of chLGP2 residues with the 10
conserved motif they belong to and the atom involved in the interaction. Polar in
interactions by an arc. Numerous direct or water-mediated interactions are omi
50-G1:C1*-30 is the first base pair from the tail end). The two observed alternative
(C) Details of the chLGP2-RNA interactions that cap the blunt end of the 50ppp ds
the capping loop, Glu571 and His574 from the 30 end-binding loop, and His406
(D) Comparison of chLGP2 structures with 50ppp-dsRNA without (gray) or with (co
and rearrangement of the b3-a4 loop accommodates the 30 end extrusion.
(E) Schematic diagram showing interactions with the 30-GG overhang nucleotide
(F) Structural details of the network of interactions between chLGP2 and the 30-
interact with C1* ribose.
See also Figures S4 and S5.binding compared to the helicase domain and reveals the coop-
erativity of dsRNA binding to the two domains.
chLGP2 Binds One Extra Base Pair of dsRNA Compared
with RIG-I
An intriguing observation is that the blunt end of the dsRNA is
located 1 bp deeper into the chLGP2 CTD than occurs in RIG-I
(Figure 3A). This is not because the entire CTD is raised up but
because the capping loop of LGP2 is flat, whereas that of RIG-I
bends downward placing the side chain of Phe853 at the same
level as the blunt-end base pair in LGP2 (Figure 3A). This shifts
all the canonical contacts between helicasemotifs and backbone
phosphates 1 bpdown from the blunt end in LGP2comparedwith
RIG-I,withmotifs Iband Iccontactingphosphate1andphosphate
2 of the 30 strand in RIG-I and LGP2, respectively (Figure 3A).
Consequently, the overall footprint of LGP2 on dsRNA is 10 bp
for LGP2 rather than 9 bp for RIG-I, consistent with the larger
surface area of protein-RNA contact for LGP2.
chLGP2 Binds to dsRNA with Modified 50 and 30 Ends
To further characterize RNA binding to chLGP2, we determined
structures with the 50ppp form the same 10-mer dsRNA (i.e., the
cognate RIG-I ligand) and a 50ppp hairpin dsRNA with 30 GG
overhang at 2.2 A˚ (chLGP2-10ppp) and 2.0 A˚ (chLGP2-30ovg)
resolution, respectively (Table 1). Note that the hairpin stem
has some base pair differences from the 10-mer dsRNA beyond
the second base pair (Figure S4). We also measured the binding
affinity of chLGP2 to different RNAs with and without various
nucleotides and compared the results with hRIG-I (Figure 3B).
In the chLGP2-10ppp structure, the 50 end has a unique
conformation (corresponding to one of the chLGP2-10p confor-
mations), with the 50ppp being accommodatedwithout structural
changes. The a- and b-phosphates interact with His406, Ser407,
and Asn408 from the Hel2-loop, and the b- and g-phosphates
interact with Lys634 (Figure S4A). An octahedrally coordinated
magnesium ion directly interacts with the a- and b-phosphates
as well as the phosphate of G2 (Figure 2C). The 50ppp conforma-
tion in the chLGP2-30ovg structure is different and resembles
the other 50 end conformation observed in the chLGP2-10p
structure. The tri-phosphate makes alternative interactions
with Asn408, Arg607, and Lys634, and there is no boundmagne-
sium (Figure S4B).
The chLGP2-3ovg structure is overall similar to the previous
structures, the major difference being a shift of the first G1-C1*
base pair toward Hel1, a slight shift in the opposite direction of
the CTD (including the capping and 30 end-binding loops), and a-mer dsRNA. Residues are colored according to domain and labeled with the
teractions are indicated with a blue dotted line (cutoff 3.5 A˚) and hydrophobic
tted for clarity. The 30 strand nucleotides are numbered with an asterisk (i.e.,
conformations of the first and second 50 phosphates are shown.
RNA showing the role of aromatic residues Phe595, Phe599, and Trp602 from
from the Hel2-loop. The Mg2+ coordinated by the 50ppp is a magenta sphere.
lors) a 30-GG overhang, showing how a slight displacement of the capping loop
s (denoted G-1* and G-2*), annotated as in (B).
GG overhang nucleotides. Compared with (C), Glu571 and His574 no longer
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Figure 3. Comparison of chLGP2 and hRIG-I Binding to dsRNA
(A) Structural and schematic diagrams comparing themode of end binding of chLGP2 and hRIG-I illustrating the extra base pair sequestered by chLGP2, which is
at the same level as Phe853 from the capping loop of RIG-I. Conserved interactions with motifs Ia, Ib, and Ic are shown.
(B) Kd values between chLGP2 (green), full-length hRIG-I (red), and chMDA5 (blue) and a 12-mer dsRNA with different 5
0 modifications were measured without
nucleotide (noNTP) andwith various nucleotides (ADP-AlF4, ADP, ATP). The values shown correspond to Kd (nM) ± SD on the basis of the fluorescence anisotropy
binding curves shown in Figure S5B.
See also Figures S4 and S5.
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Figure 4. Overall Structure of chMDA5DCARD-ADP Complex
(A) Domain structure of chMDA5DCARD, omitting the N-terminal tandem CARD domains.
(B) Ribbon diagram of the chMDA5DCARD-10-mer dsRNA-ADP complex from head end along (left) and perpendicular (right) to the dsRNA axis, colored
according to Figure 2A.
(C) Diagram showing the interactions of chMDA5 with ADP:Mg.
(legend continued on next page)
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significant rearrangement of the b3-a4 loop (residues 79–90),
whichwouldotherwiseclashwith theadditional bases (Figure2D).
The net result is to disengage Glu571 and His574 from the ribose
of C1 allowing 30 extension of the RNA by extrusion of overhang
nucleotide G-1* between the capping loop and the refolded
b3-a4 loop. The G-1* base is stacked between the side chains
of Arg600 and Lys87, and the resulting conformation of the
b3-a4 loop permits G-1* andG-2* tomake numerous interactions
with residues 79–90, including a number of base-specific interac-
tions (Figures 2E and 2F). This together with the burial of the G-2*
ribose, whose 30 OHmakes a hydrogen bond to the phosphate of
C1*, suggests that the observed structure may be specific to this
particular 30-GG overhang but does show how relatively minor
structural perturbations allow extrusion of a 30 overhang, while
extension of the double helical stem is prevented bymaintenance
of the stacking of the capping loop over the first base pair.
The affinities of LGP2 to various dsRNA ligands were deter-
mined by fluorescence anisotropy (Figure 3B). chLGP2 binds
to a blunt-end 12-mer dsRNA with an affinity independent of
whether the 50 is a hydroxyl or a tri-phosphate (Figures 3B and
S5B), consistent with the lack of significant additional inter-
actions to the tri-phosphate (and its variable conformation)
observed in the crystal structures. By comparison, hRIG-I, as
expected, binds to 50ppp more tightly than to 50-OH dsRNA, a
result of the interactions of the 50pppwith three lysines and a his-
tidine, all strictly conserved (Luo et al., 2012). In addition, while
hRIG-I’s affinity to 50ppp dsRNA depends on which nucleotide
is also bound, being highest for ADP:AlF4 (Kd  1 nM) and 20
times weaker with ADP or no nucleotide (Figure 3B), the affinity
of chLGP2 for dsRNA is independent of bound nucleotide (Fig-
ure 3B). Finally, consistent with the 30-ovg structure, the affinity
of chLGP2 for 30 and 50 overhangs is only marginally reduced
by a factor of two. In comparison, hRIG-I can also bind 30 over-
hangs with high affinity (provided there is a 50ppp), but 50 over-
hangs are far less well accepted (Ramanathan et al., 2016).
Overall Structure of chMDA5
In the absence of endogenous RIG-I, it is thought that chMDA5,
perhaps in co-operation with chLGP2, is responsible for the
RNAdependent anti-viral response to viruses that are usually de-
tected by RIG-I (Liniger et al., 2012). We therefore determined
the crystal structure of chMDA5 (see Figure 4A for the domain
structure) and investigated its ability, as well as that of chLGP2,
to form filaments with dsRNA.
For co-crystallization, we used 50p palindromic duplex RNAs,
the ATP analog AMPPNP, and a construct denoted chMDA5D
CARD-Q, comprising the helicase and CTD (residues 298–994)
with themutation E436Q and lacking seven residues at the C ter-
minus. The E436Q mutant in conserved motif II (i.e., DECH be-
comes DQCH) virtually abolishes ATPase activity (Louber et al.,
2015) and for another DEAD-box helicase, VASA, permitted trap-
ping of the helicase substrate RNA (Xiol et al., 2014). Unlike for
the hMDA5 crystal structure (Wu et al., 2013) the long, acidic(D) Diagram showing how Glu369 emerges from helix a3 to be involved in ribose
similar situation occurs in LGP2 but not RIG-I (see Figure 1D).
(E) Ribbon diagram of the head-to-head chMDA5DCARD-24-mer dsRNA-ADP
according to Figure 2A, with lighter colors for the second monomer.
594 Molecular Cell 62, 586–602, May 19, 2016loop between helixes a12 and a13 of Hel2i, which is 17 residues
shorter in chMDA5, was not deleted (Figure S1). The structure of
a 1:1 complex of chMDA5DCARD-Q with ADP:Mg2+ and 10 bp
dsRNA (chMDA5-10) and a 2:1 complex with 24 bp dsRNA
(chMDA5-24) were solved by molecular replacement at 2.60
and 2.75 A˚, respectively (Table 2), as well as a 2:1 complex
with 27 bp dsRNA at 7.2 A˚ resolution.
Overall, the chMDA5-dsRNA structures resemble that of
hMDA5 bound to a 12-mer dsRNA (PDB: 4GL2; root-mean-
square deviation of 1.16 A˚ for all Cas) (Figure 4) but with consid-
erably higher resolution (hMDA5 is at 3.56 A˚), and the model is
more complete. Interestingly, the hMDA5, chMDA5-10 (Fig-
ure 4B), chMDA5-24 (Figure 4E), and chMDA5-27 structures all
capture the dsRNAs bound in different longitudinal positions.
The chMDA5-24 and chMDA5-27 structures reveal two different
2:1 complexes with two MDA5 molecules bound to the same
dsRNA. Following Wu et al. (2013), looking perpendicular to
the RNA axis, we denote the head end of MDA5 as the pincer
domain containing face and the tail end as that containing the
CTD (see Figures 4B and S1 for the secondary structure of
chMDA5 and sequence alignments).
chMDA5 Bound to dsRNA and ADP:Mg2+ Is in the Semi-
closed Conformation
In all chMDA5-dsRNA structures, the helicase is in the semi-
closed conformation (Figures 4B and S6; Table S1), but unlike
the semi-closed forms of RIG-I and LGP2, Hel2 is well ordered.
In the two higher resolution structures, the electron density in
the nucleotide binding site clearly corresponds to ADP:Mg2+,
presumably becauseof slowAMPPNPhydrolysis. TheADP:Mg2+
is bound in canonical fashion by motifs Q and I, with the adeno-
sine stacked between Arg330 (motif I) and Arg302 (motif Q) (Fig-
ure 4C). This arrangement is more similar to that in chLGP2 than
RIG-I, with helix a3 being kinked toward the nucleotide binding
cleft in the same way, allowing Glu369, stabilized by Arg330, to
hydrogen-bond to the 30 OH of ADP (corresponding to Glu67
and Arg32 in chLGP2; compare Figures 1D and 4D).
chMDA5 Interaction with dsRNA
MDA5binds to the dsRNA stemusing the canonical helicasemo-
tifs Ia, Ib, Ic, IIa, IV, IVa, and V as well as conserved glutamines
Gln568 andGln572 from a10 of Hel2i, in a similar manner to other
RLHs (Figure 5). The distinguishing feature of MDA5 (Wu et al.,
2013) is that its CTD interacts intimately with Hel2i and is dis-
placed relative to the position in LGP2 or RIG-I to allow a dsRNA
helix to pass through the molecule. Thus, the domain arrange-
ment in MDA5, at the tail end, resembles an open horseshoe
rather than a closed circle (compare Figures 5A and 2A).
The Hel2-loop (729–740 in chMDA5, notably residues His733,
Asn734, and Lys738; Figure S1), senses the major groove of
thedsRNA, as in LGP2andRIG-I, butwithoutmakingany specific
interactions (Figure 5C). The CTD 30 end-binding loop (898-
ENMH-901 in chMDA5) contacts the backbone of the 50 strand,binding and stabilization of Arg330, which stacks on the adenine base. A very
complex perpendicular to the dsRNA axis. Domains and dsRNA are colored
Table 2. Diffraction Data and Refinement Statistics for chMDA5
Crystal chMDA5
50p 10-mer dsRNA
ADP-Mg2+
Twinned
chMDA5
50p 10-mer dsRNA
ADP-Mg2+
chMDA5
50p 10-mer dsRNA
ADP-Mg2+
Untwinned
chMDA5
50p 24-mer dsRNA
ADP-Mg2+
Diffraction data
Space group P21 P212121 P21 P212121
Cell dimensions (A˚) a = 70.16, b = 138.70,
c = 100.42
a = 101.92, b = 132.47,
c = 139.04
a = 72.08, b = 139.73,
c = 103.19
a = 99.75, b = 133.40,
c = 138.44
a = g = 90, b = 109.48 a = b = g = 90 a = g = 90, b = 110.142 a = b = g = 90
Wavelength (A˚) 0.9724 0.9763 0.9763 0.9724
Resolution range of data (last shell) (A˚) 50.0–2.60 (2.69–2.60) 50.0–2.60 (2.69–2.60) 48.6–2.95 (3.06–2.95) 50.0–2.75 (2.82–2.75)
Completeness (last shell) (%) 99.3 (99.6) 98.2 (99.2) 94.0 (96.6) 99.1 (99.2)
R-sym (last shell) (%) 9.60 (89.6) 9.60 (99.2) 9.4 (87.3) 16.8 (80.9)
I/sI (last shell) 9.83 (1.73) 10.31 (1.87) 9.94 (1.78) 6.58 (1.52)
Redundancy (last shell) 3.52 (3.63) 5.06 (5.21) 5.20 (5.05) 4.66 (4.89)
Refinement
Reflections used in refinement work (free) 52,489 (2,811) 54,624 (2,901) 36,153 (1,907) 45,840 (2,433)
R-work (last shell) 0.271 (0.273) 0.277 (0.401) 0.256 (0.423) 0.290 (0.487)
R-free (last shell) 0.290 (0.286) 0.312 (0.418) 0.270 (0.421) 0.322 (0.492)
Number of non-hydrogen atoms 11,761 11,870 11,661 11,616
Protein 10,851 10,773 10,751 10,539
RNA 854 873 854 1,021
Ligand (nucleotide) 56 56 56 56
Solvent – 168 – –
Geometry
Rms (bonds) 0.007 0.007 0.008 0.008
Rms (angles) 1.11 1.06 1.28 1.21
Ramachandran favored (%) 96.3 96.0 95.8 93.7
Ramachandran outliers (%) 0.31 0.31 0 0.4
Clash score 1.08 0.39 0.48 1.4
Average B factor 58.1 67.2 81.7 70.0
Protein 59.1 67.2 83.5 71.2
RNA 44.4 56.2 58.6 56.9
Ligand 59.5 65.1 96.1 74.0
Solvent – 49.1 – –
Rms, root-mean-square.without blocking extension of the 30 end, and the conserved 977–
980 turn, toward the end of the CTD, also makes backbone inter-
actions to both strands in the major groove (Figure 5C). Another
major distinctive feature of MDA5 is the position and nature of
the CTD ‘‘capping loop’’ (918–927 in chMDA5; Figure S1). While
in all MDA5 crystal structures with dsRNA this loop is disordered,
it is well structured in the isolated hMDA5 CTD structure (PDB:
3GA3), revealing it to be more compact than in LGP2 or RIG-I.
Moreover, the MDA5 loop, unlike those of LGP2 and RIG-I, lacks
the bulky hydrophobic residues that would favor interaction with
a blunt end base pair. Modeling of the loop from the superposed
hMDA5 CTD structure suggests that when binding to a contin-
uous dsRNA the capping loop and N-terminal end of a16 of
Hel2 could favorably interact with theminor groove and extended
50 strand backbone, respectively (Figure 5D).Dimers of chMDA5 on dsRNA Have the Head-Head
Configuration
In the chMDA5 24-mer structure, two MDA5 molecules are
stacked head to head on one dsRNA, with a two-fold symmetry
axis perpendicular to the dsRNA and between the twomolecules
(Figures 4E and 6A); additionally there is a 35 bend in the dsRNA
axis (Figures 6A and 6B). In the chMDA5 10-mer structure, there
are two1:1 complexes in theasymmetric unit,which arearranged
exactly as in the 24-mer structure except that the dsRNA is not
continuous, lacking one base pair between the molecules (Fig-
ures 6A and 6B). The hMDA5 12-mer structure has two 1:1 com-
plexes in the asymmetric unit, but with no pseudo-continuous
RNA helix running through multiple MDA5molecules. Compared
with the chMDA5 10-mer structure, the hMDA5 12-mer structure
has three extra base pairs at the tail end but one fewer at the headMolecular Cell 62, 586–602, May 19, 2016 595
A B
C D
Figure 5. Interactions of chMDA5 with
dsRNA
(A) Head and tail views down the dsRNA axis of the
chMDA5 structure showing that the dsRNA can
continue from both ends (see also D). Compared
with LGP2 (Figure 2A), MDA5 appears from the tail
end as an open horseshoe rather than a disk.
(B) Schematic diagram showing the interactions of
chMDA5 residues with the 10-mer dsRNA, anno-
tated as in Figure 2B.
(C) Ribbon diagram showing protein-RNA in-
teractions in the chMDA5 10-mer structure at
different levels along the dsRNA, including those
from helix a12 of Hel2i, the Hel2 loop, and two loops
of the CTD. The putative position of the disordered
MDA5 capping loop is shown dotted on the basis of
the crystal structure of the isolated hMDA5 CTD.
Protein-RNA interactions mediated by the Hel1 and
Hel2 domains have been omitted for clarity (see B).
(D) As in (C), but the dsRNA has been extended by
3 bp to emerge from the tail end of the molecule.
Modeling suggests that the MDA5 capping loop
could be involved in another level of protein-RNA
interactions as well as possibly mediating the tail-
to-head protein-protein interface.end (Figures 6A and 6B). By comparison, the chMDA5 24-mer
structure gains 1 bp at the head end (making the dsRNA contin-
uous between the two molecules) and 1–2 bp at the tail end
(because the 24-mer structure probably corresponds to a super-
position of two structures with a shift of 1 bp). More base pairs at
the tail end correlate with a slight movement of the CTD toward
the dsRNA. The bend in the dsRNA axis in the 1:1 and 2:1
chMDA5 structures allows two MDA5 molecules to pack closely
together in head-to-head fashion, with a center-of-mass to cen-
ter-of-mass distance of 43.1 A˚ and total buried protein-protein
surface of 1,961 and 1,907 A˚2, respectively. The head-to-head
interface involves two-fold symmetric interactions between the
pincer domain of one molecule and two protruding loops of the
other molecule (Figure 6C). The beginning of the pincer domain
(812-SGSAVER-817) interacts with the loop preceding Hel1 helix
a9 (489-RSNS-492), which protrudes from the surface of the
neighboring molecule. The end of the pincer domain (852-
LQSI-855) interactswith the loop (562-KSE-564) between helices
a11anda12of the secondmolecule.Note that residuesV816and
E817 in chMDA5 are equivalent to I841 and E842, implicated in
the head-to-tail interaction in hMDA5 (Wu et al., 2013).596 Molecular Cell 62, 586–602, May 19, 2016In the chMDA 27-mer complex, the
dsRNA is straight. Moreover, compared
with the 24-mer complex, the two MDA5
head-to-headmolecules aremore distantly
separated by 48.7 A˚, and their relative rota-
tion differs, with the secondmolecule of the
27-mer dimer being rotated a further 106
around and translated 10.6 A˚ further along
the dsRNA (Figures 6A and 6B). Only
regions 852–855 and 562–564 are close
enough to make contact, thus reducing
the total buried surface area to 484 A˚2.Thus, whereas in the case of the 24-mer 2:1 complex, stronger
protein-protein interactions are able to distort the path of
the dsRNA, the 27-mer structure paradoxically suggests that
chMDA5 prefers to bind at the end of a short dsRNA, even if this
means reducing protein-protein interactions. However, it cannot
be ruled out that the observed arrangement is dependent on crys-
tal contacts.
chLGP2 Makes Filaments with dsRNA
To test the ability of chLGP2 to form filaments on continuous
dsRNA, complexes with F6 2,948, 4,063, and 6,374 bp long
dsRNA were studied by EM. When mixed with a protein/RNA ra-
tio of 0.2:1 in the presence of 2 mMATP and imaged using nega-
tive stain, chLGP2 forms short and discrete multimeric clusters
on F6 dsRNA (Figure 6D). At a ratio of 1:1, corresponding to
one protein per 15 bp, as in hMDA5 polar filaments (Berke
et al., 2012; Wu et al., 2013), more extensive and regular dsRNA
coating interspersed with naked dsRNA is observed (Figure 6D).
The presence of ATP or ADP:AlF4 favors the formation of fila-
mentous regions. In comparison, at a 1:1 ratio, full-length
chMDA5 completely coats dsRNA, independently of bound
hMDA5 1 to 1 12 mer chMDA5 1 to 1 10 mer chMDA5 2 to 1 24 mer chMDA5 2 to 1 27 mer
A
43.1 Å 48.7 Å
2D class average and Power spectrum 
2D class average and Power spectrum 
812-SGSAVER-817
489-RSNS-492
852-LQSI-855
562-KSE-564
44 Å
44 Å
chLGP2
Ф6dsRNA
ATP
chMDA5
Ф6dsRNA
ATP
B
D
E
C
 dsRNA bend by 35°  dsRNA straight dsRNA bend by 35°
106°
1 : 1 
1 : 1 cryo image 1 : 1
cryo image 1 : 10.2 : 1 
0.2 : 1
Figure 6. Dimer and Filament Formation by chMDA5 and chLGP2
(A) Comparison of monomeric and dimeric structures of MDA5-dsRNA complexes. hMDA5 12-mer (PDB: 4GL2) (left), chMDA5 10-mer (middle-left), chMDA5
24-mer (middle-right), and chMDA5 27-mer (right). In all cases, the bottom molecule (green ribbons with CTD in orange, pincer domain in red) is in the same
orientation. The topmolecule is cyan except for the pincer domain (pink). The chMDA5 10-mer and 24-mer structures are essentially the same apart from the lack
of continuity of the dsRNA in the former. In both cases, the axis of the dsRNA is bent by 35 between the two head-to-headmolecules, but in the chMDA5 27-mer
complex, it is straight.
(legend continued on next page)
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Figure 7. Cooperativity of LGP2 with MDA5 in Cells
(A) Enhancement of poly(I:C)-mediated activation of endogenous chMDA5 by exogenously supplied chLGP2 (27.5 ng DNA/well) in chicken DF1 cells. See also
Figures S7A–S7C.
(B) Effect of chLGP2, chLGP2 variants (K138E/R490E or hel, K648E/K649E or CTD, K138E/R490E/K648E/K649E or helCTD), and hLGP2 (27.5 ng DNA/well)
on the activation of chIFNb promoter by endogenous chMDA5 stimulated (yellow bars) or not (blue bars) by poly(I:C) and by exogenous chMDA5 (1.67 ng
DNA /well) in the absence (black bars) and presence (green bars) of poly(I:C) in chicken DF1 cells. *p < 0.05 and **p > 0.025 and below. Comparison of
endogenous MDA5 and exogenous MDA5 co-transfected or not with LGP2 and activated or not with poly(I:C) are in black, LGP2 activated chLGP2 variants with
WT counterpart are in red (effect on endogenous chMDA5), blue (effect on exogenous chMDA5), and green (effect on exogenous chMDA5 + poly[I:C]). Data are
mean ± SD of three independent experiments, with each combination done in triplicate each time. See also Figures S7D–S7F.
(C) Effect of hLGP2 on the activation of exogenous hMDA5 and hMDA5 IE/KR (1.67 ng DNA/well) (I841K/E842R) mutant by poly(I:C) (denoted [I:C]) in the absence
(white bars) and presence (black bars) of exogenously supplied hLGP2 (27.5 ng DNA/well) in human Huh7.5 cells. **p < 0.01 and ***p > 0.0025. Background signal
(mean value) of cells transfected with control plasmid DNA followed or not by transfection of poly(I:C) is indicated by the shaded area. See also Figure S7G.
See also Figure S7.nucleotide, and at a ratio of 0.2:1, long clusters are observed on
a few dsRNA molecules (Figure 6E). Thus, chLGP2 binding
to dsRNA is less co-operative than chMDA5 (this work) and
hMDA5 (Berke et al., 2012; Peisley et al., 2011; Wu et al.,
2013). Imaging of chLGP2 and full-length chMDA5 filaments by
cryo-EM shows that they are qualitatively similar, with a subunit
axial translation of 44 A˚ (Figures 6D and 6E), identical to that
reported for hMDA5 (Berke et al., 2012).
Functional Studies of LGP2/MDA5 Cooperativity
The mechanism of chLGP2 stimulation of chMDA5 function was
investigated using the RNA binding-deficient chLGP2mutants in
the CTD, helicase, or both, which we characterized above and
monitoring IFN-b activation in chickenDF1 cells upon stimulation
with poly(I:C). Exogenously provided chLGP2 readily augments(B) Schematic representation of (A) highlighting the dsRNA conformation. The di
dimer is indicated. Compared with the hMDA5 12-mer structure (left), the chMDA
head end, and there is a 1 bp gap between the RNAs in the two head-to-head mo
the structure). In the chMDA5 24-mer (middle right), the dsRNA is continuous betw
MDA5 molecules and 24 bp overall, the structure is likely a superposition of stru
indicated by the dashed line. In the low-resolution chMDA5 27-mer, it is unclear wh
separated, or at the tail ends, but the dsRNA is straight.
(C) Detail of the four regions involved in protein-protein interactions mediating th
(D) EM analysis of chLGP2:F6 dsRNA complexes in the presence of ATP. Left: mo
negative stain. Middle right: molar ratio 1:1 with cryo-EM. Right: cryo-EM image
(E) EM analysis of chMDA5:F6 dsRNA complexes in the presence of ATP. Left: mo
Middle right: molar ratio 1:1 with cryo-EM. Right: cryo-EM image 2D class avera
598 Molecular Cell 62, 586–602, May 19, 2016the response of endogenous chMDA5 to poly(I:C) (Figures 7A
and S7A), as also found in the human system (Figures S7B and
S7C), whereas LGP2 itself lacks transduction ability (Figures
7B and S7D) (Rothenfusser et al., 2005). Unlike the human sys-
tem, in which exogenous hMDA5 exhibits a constitutive activity
not enhanced by exogenous hLGP2 (Figure S7D, no RNA), exog-
enous chMDA5 lacks constitutive activity, but co-transfection
with chLGP2 results in significant activation of the chIFNb
promoter (Figure 7B, compare WT and Ø, blue bars) suggest-
ing that chLGP2 overexpression can stabilize the binding of
chMDA5 to cellular RNAs (as found with ATP hydrolysis mutants
of MDA5; Louber et al., 2015). Co-transfection of chLGP2
has a strong enhancing effect on the activation of limiting
amounts of exogenous chMDA5 by poly(I:C) (Figure 7B,
compare green and blue bars for wild-type chLGP2), similar tostance between the center of mass of the two molecules in the head-to-head
5 10-mer structure (middle left) lacks 3 bp at the tail end and gains 1 bp at the
lecules in the dimer (dotted base pairs indicate potential extra base pairs not in
een themolecules in the dimer but bent. Because there is 1 bp between the two
ctures with either 11 or 12 bp bound to one MDA5 (i.e., 11.5 on average), as
ether there are extra base pairs between themolecules, which aremore widely
e head-to-head packing.
lar ratio 0.2:1 with uranyl acetate negative stain. Middle left: molar ratio 1:1 with
2D class average and power spectrum.
lar ratio 0.2:1 with negative stain. Middle left: molar ratio 1:1 with negative stain.
ge and power spectrum.
the dose-dependent enhancement observed in the human sys-
tem (Figures S7D and S7E) (Bruns et al., 2013, 2014; Pippig
et al., 2009). Enhancing activities were most evident when either
MDA5 or poly(I:C) was in limited amounts. Furthermore there ap-
pears to be a species restriction, as hLGP2 readily enhances
hMDA5 activation in human Huh7.5 cells (Figures S7C–S7E)
but is inactive toward chMDA5 in DF1 cells (Figure 7B). RNA
binding-deficient chLGP2 mutants in the CTD, helicase, or
both show poor enhancing activity toward chMDA5 (Figure 7B,
CTD, hel, and CTD-hel constructs), also observed in the hu-
man system (Figure S7F). Finally, hLGP2 also exhibited a potent
enhancing effect on the poly(I:C)-mediated activation of the
hMDA5 IE/KR mutant, which has been reported to be deficient
in signaling because of a defect in homopolymerization (Louber
et al., 2015;Wu et al., 2013) (Figure 7C), this property being abro-
gated with RNA binding-deficient hLGP2 mutants (Figure S7G).
DISCUSSION
We describe unusually high-resolution crystal structures of
chLGP2 bound to dsRNA and ADP:AlF4, which show chLGP2
to be in the fully closed, ATP hydrolysis transition state. chLGP2
binds to dsRNA with its CTD capping the blunt end, similarly to
RIG-I, but differs in having a longer overall footprint and by
accommodating 50 or 30 overhangs with relatively minor pertur-
bations in structure and little loss in affinity.
We also present several structures of chMDA5, all of which are
in the semi-closed state with ADP:Mg2+ bound. chMDA5 seems
to prefer head-to-head packing when bound to short dsRNA
(24-mer to 27-mer) in contrast to the polar head-to-tail packing
described for long, signaling active hMDA5-dsRNA filaments
(Berke et al., 2012; Wu et al., 2013). chLGP2 also forms filaments
on dsRNA structurally resembling those of MDA5, although
chLGP2 dsRNA coating is less co-operative.
Functionally, conserved RNA binding determinants in both the
CTD and helicase are required for LGP2-mediated enhancement
of MDA5 signaling in both chicken and human, suggesting a
conserved underlying mechanism for this phenomenon.
Open and Closed Helicase Conformations of RLHs
Structures of RIG-I and MDA5 can be classified into four states
depending on the degree of closure of the Hel1 and Hel2 do-
mains, and this is usually correlated to the type of bound nucle-
otide (Table S1; Figure S6A). RNA free structures of full-length
RIG-I (in which the CARDs are bound to Hel2i) or the helicase
domain alone are in the very flexible ‘‘open’’ conformation with
Hel1 and Hel2 well separated and Hel2 poorly ordered (Kowalin-
ski et al., 2011; Civril et al., 2011; Deimling et al., 2014). Most
hRIG-I helicase-CTD-dsRNA structures with no nucleotide, sul-
fate, or ADP are in the ‘‘semi-open’’ conformation with the poorly
ordered Hel2 not contacting the RNA (Kohlway et al., 2013; Luo
et al., 2011, 2012). In one ‘‘semi-closed’’ state structure, co-crys-
tallized with ATP analog ADP:BeF3, Hel2 is better ordered, but
motifs V and VI do not engage with the nucleotide (Jiang et al.,
2011). The only fully ‘‘closed’’ RIG-I structure in which all motifs
are correctly positioned for ATP hydrolysis, is that of the isolated
dRIG-I helicase domain bound to dsRNA and ADP:AlF4 (Kowa-
linski et al., 2011). The closed conformation of the chLGP2-dsRNA-ADP:AlF4 complexes reported here thus closely resem-
bles the latter dRIG-I structure. In contrast, the chLGP2 12-mer
dsRNA structure without nucleotide is semi-closed with Hel2
poorly ordered, except where it contacts the RNA. Intriguingly,
a closed structure of RIG-I including the CTD and an ATP analog
has not yet been reported.
To characterize quantitatively these different conformations,
we superposed, via the Hel1 domain, all RLH structures on the
chLGP2 closed state as reference. The rotation angle required
to superpose the Hel2 domain of the test structure on that of
the reference structure varies systematically in concordance
with the qualitative description above, being 0 to 3 for the
closed state, 7 to 13 for the semi-closed state, 40 for the
semi-open state, and 50 to 60 for the open state (Table S1).
The two different chLGP2 conformations described here
provide a unique opportunity to compare the closed and semi-
closed states of the same RLH. The 10 rotation of Hel2
between the closed state and semi-closed states corresponds
to a shift of the backbone interactions made by Hel2 (mediated
by motifs IVa and V) by one phosphate down the 30 strand of
the dsRNA, whereas the interactions of Hel1 (mediated bymotifs
Ia, Ib, Ic, and IIa) with the dsRNA are unchanged (Figures S6B
and S6C). The movement of Hel2 is coupled to that of Hel2i,
which pivots around its contact with the CTD (which itself does
not shift much), while maintaining similar contacts with the
RNA (Figure S6B). This comparison highlights an ATP-depen-
dent structural transition, which in one sense can correspond
to a co-operative tightening of dsRNA interactions upon ATP
binding and in the other sense the relaxation of the grip upon
the dsRNA upon ATP hydrolysis. This structural transition needs
to be taken into account in understanding the role of ATP binding
and hydrolysis in RLH function, including filament formation.
End Binder and/or Stem Binder?
The stem binder MDA5 and end-capping LGP2/RIG-I critically
differ in the position of the CTD and the nature of the residues
on the CTD ‘‘capping loop’’ (Figure S1). In LGP2 and RIG-I
‘‘capping loop’’ aromatic hydrophobic amino acids (Phe595,
Phe599, and Trp602 in chLGP2; Phe853 and Phe856 in hRIG-I)
contact the blunt-end base pair of the dsRNA by edge-on or
stacking interactions, essentially preventing binding to a contin-
uous stem. In MDA5, the loop contains no bulky hydrophobic
residues and is disordered in all structures of MDA5 bound to
dsRNA so far. However, it is ordered in the structure of the
hMDA5 CTD alone (PDB: 3GA3), where it forms an additional
b strand to the main b sheet of the CTD rather than bulging out
as in RIG-I and LGP2 (Figure 5D). As pointed out previously
(Wu et al., 2013), MDA5 CTD is significantly displaced away
from the dsRNA compared with RIG-I and is able to pack closer
to Hel2i because of the 10 residues shorter a12 in MDA5Hel2i. In
chMDA5, the pining of the CTD to Hel2i is reinforced by thewrap-
ping of the extended loop between a14 and a15 of Hel2i (resi-
dues 629–646) over the CTD (e.g., Asp635 interacts with
His914 and Arg916 of CTD domain). In chMDA5, this a14-a15
loop is shorter than that of hMDA5 (638–670) but longer than in
RIG-I or LGP2. The close CTD-Hel2i interaction combined with
the less hydrophobic and less intrusive CTD capping loop allows
MDA5 to bind internally to dsRNA.Molecular Cell 62, 586–602, May 19, 2016 599
Interestingly, chLGP2 resembles a chimera, combining a
MDA5-like helicase domain and a RIG-I like CTD. The similarity
of LGP2 to MDA5 is reflected in common structural features,
not found in RIG-I, such as the mode of nucleotide binding (Fig-
ures 1D and 4D) and the length of the Hel2i domain helices (Fig-
ure S1) and susceptibility to protein V. However, the hydrophobic
nature of the LGP2 CTD capping loop is clearly RIG-I like. Corre-
sponding to these mixed structural features, LGP2 has the
strong blunt-end binding characteristic of RIG-I yet is also able
to make MDA5-like filaments, albeit less efficiently. Perhaps
the chimeric nature of the LGP2 structure allows its CTD to adopt
a different position closer to Hel2i, allowing LGP2 to form fila-
ments similarly to MDA5, whereas RIG-I does not form well-or-
dered, extended filaments. The similarity in overall appearance
and axial subunit translation of LGP2 filaments to MDA5 fila-
ments suggests that LGP2 could also form head-to-tail packing
on long dsRNA. Furthermore, modeling suggests that in MDA5,
the capping loop could not only play a role in dsRNAbinding (Fig-
ure 5D) but also be involved in the tail-to-head protein-protein
interface. The same could be true in the case of LGP2, although
it is unclear what alternative interactions the aromatic residues
on the capping loop of LGP2might make. This and related ques-
tions will be answered only by high-resolution EM reconstruc-
tions of LGP2 and MDA5 filaments.
Head-to-head and Head-to-Tail Packing of MDA5
The head-to-head arrangement we observe for dimers of MDA5
bound to short dsRNA contrasts with the intermolecular packing
arrangement derived from EM reconstructions of mouse MDA5-
coated dsRNA filaments, which exhibit a polar head-to-tail
packing (Berke et al., 2012; Wu et al., 2013). When the chMDA5
structure was fitted into the EM map of the helical filament, the
superposition also showed that the head-to-tail configuration
fits significantly better (correlation coefficient 0.87 compared
with 0.78 for head to head). However, the chMDA5-24 structure
indicates that on short dsRNA, and in the absence of stabilizing
co-operative interactions forming an extended multimer, head-
to-head stacking appears to be the preferred mode of interac-
tion, and head-to-tail packing has not yet been observed in
any crystal form. Thus it is possible that a head-to-head dimer
nucleates filament formation. Interestingly, Dicer-related heli-
case 3, an ortholog of the Dicer and RIG-I that is essential for
secondary small interfering RNA production in Caenorhabditis
elegans, binds and recognizes 22G-RNA as a dimer, which has
been modeled as a head-to-head dimer (Fitzgerald et al., 2014).
Biological Role of LGP2 as a Regulator of RLH Signaling
Various hypotheses exist as to howLGP2might play positive and
negative roles in RLH signaling (Rodriguez et al., 2014). The high
affinity of LGP2 end binding to short dsRNA supports that it
could potentially compete for cognate RIG-I ligands and thus
exert a negative effect, as proposed by others (Pippig et al.,
2009; Rothenfusser et al., 2005). However, the affinity for
50ppp-dsRNA is slightly lower than for RIG-I, suggesting that
an excess of LGP2 over RIG-I might be required, as observed
by others (Childs et al., 2013). Such a high unbalance between
the two proteins, both of which are similarly transcriptionally
upregulated by type I IFN (Rothenfusser et al., 2005), remains600 Molecular Cell 62, 586–602, May 19, 2016to be demonstrated in natural infection conditions. LGP2 has a
considerably higher affinity for non-phosphorylated blunt-end
dsRNA than RIG-I and thus could act as sponge to prevent mis-
activation of RIG-I by such RNAs, which may exist in the host
cell. This would be an additional mechanism to promote self-
discrimination or non-self-discrimination by RIG-I in parallel
with the recently recognized role of the RIG-I ATPase activity
and the CARD2-Hel2i interface to prevent deleterious constitu-
tive activation of RIG-I by more weakly binding, non-cognate
cellular RNAs (Anchisi et al., 2015; La¨ssig et al., 2015; Louber
et al., 2015; Ramanathan et al., 2016; Rawling et al., 2015).
The mechanism of enhancement of MDA5 signaling by LGP2
in human cells has been proposed to depend on a direct effect
of LGP2 on MDA5 filament formation (Bruns et al., 2014; Childs
et al., 2013). It was concluded that LGP2 attenuates MDA5 fila-
ment length, giving rise to shorter complexes that more effi-
ciently stimulate anti-viral signaling than longer MDA5 filaments
(Bruns et al., 2014). In the chicken system, LGP2-stimulated
MDA5 signaling could work by a similar mechanism. Addition-
ally, our results suggest that LGP2 could potentially compensate
for the lack of RIG-I through high-affinity end binding to a RIG-I
like ligand, which could then nucleate, by RNA-dependent pro-
tein-protein interactions, signaling-competent MDA5 oligomer
formation. Such a mechanism is supported by the observed
strong RNA end binding mode of LGP2 (which is more permis-
sive in terms of 30 and 50 modifications than RIG-I) and the func-
tional requirement of an intact RNA binding site on both the CTD
and helicase. Interestingly, the enhancing effect is observed only
whenRNA ligand and/or MDA5 are in limited amounts, as is likely
to be the case early in infection.
In conclusion, our structural and functional results lay the basis
for further studies to elucidate the exact mechanistic role of
LGP2 in regulating MDA5 signaling by, for instance, determining
the composition and structure of mixed filaments and/or oligo-
mers containing both MDA5 and LGP2.
EXPERIMENTAL PROCEDURES
Protein Preparation and Crystallization
Purified chMDA5 (full-length, residues 1–1,001), chMDA5DCARD (residues
298–994), chMDA5DCARD-E436Q constructs, and a SUMO fusion of full-
length chLGP2 (1–674), expressed in Escherichia coli, were mixed with
dsRNA of various lengths, prepared by in vitro T7 transcription, and either
AMPPNP or ADP:AlF4 and initially screened for crystallization using a Car-
tesian robot.
Crystallography
Optimized crystals were flash frozen and diffraction data collected on various
beamlines at the European Synchrotron Radiation Facility (ESRF). Data were
processed with XDS (Kabsch, 2010) and further analyzed using the CCP4 suite
(Winn et al., 2011). Structures were determined by molecular replacement and
refined with REFMAC5 (Murshudov et al., 1997).
EM
Full-length chMDA5 or chLGP2 complexes with F6 bacteriophage dsRNA
(Thermo Scientific), with or without ATP analogs, were examined by negative
stain EM. For cryo-EM, 1:1 mixtures (one MDA5/LGP2 molecule per 15 bp
of dsRNA) were frozen on glow-discharged grids (Quantifoil Micro Tools)
and data collected with an FEI Polara microscope equipped with a K2 summit
detector (Gatan). Power spectra were calculated from masked 2D class
averages.
Fluorescence Polarization Anisotropy
chMDA5, chLGP2, or hRIG-I was titrated into dsRNA solutions made by
annealing 50-FAM-labeled 12-mer RNA with unlabeled cRNA. Anisotropic
measurements were made with excitation wavelength 495 nm and emission
wavelength 515 nm during 100 s and Kd values derived by curve fitting.
ATPase Activity Assays
dsRNA-dependent ATPase reactions were performed using aMalachite green
assay kit (Bioassays) over 0.5–30 min, as detailed previously (Louber et al.,
2015).
Cellular Assays
IFN-b promoter activation upon transient expression of expression vectors
coding for chicken or human MDA5 and LGP2 and poly(I:C) stimulation in
chicken DF1 and human Huh7.5 cells was determined as previously described
(Louber et al., 2015)
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